Cerebral vasospasm in subarachnoid haemorrhage

被引:2
|
作者
Stura, G [1 ]
Ferrio, MF [1 ]
Bergui, M [1 ]
机构
[1] Univ Turin, Molinette Hosp, Neuroradiol Unit, Dept Neurosci, I-10126 Turin, Italy
来源
RIVISTA DI NEURORADIOLOGIA | 2002年 / 15卷 / 05期
关键词
vasospasm; cerebral aneurysm; subarachnoid haemorrhage; angioplasty; papaverine;
D O I
10.1177/197140090201500519
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In the second and third weeks after a subarachnoid haemorrhage a series of mechanisms causes a decrease of the diameter of the cerebral vessels. These phenomena are globally included in the term "vasospasm". A certain degree of vasospasm is found in the majority of the patients after a subarachnoid bleeding.. This can be detected by instrumental examinations, in particular trans-cranial doppler and angiography. However, only a minor percentage of these patients will suffer clinical consequences. The vasospasm is currently treated by hypertensive-hypervolemic-haemodilution therapy (the so called "HHH" therapy), or may be treated by selective injection of vasoactive substances (Papaverine, nimodipine) or by mechanical dilatation of the involved vessels with balloons, mainly because of an improved medical management and a better monitoring of critical patients the incidence of clinical vasospasm has decreased in the recent years.
引用
收藏
页码:611 / 614
页数:4
相关论文
共 50 条
  • [1] Mechanisms of cerebral vasospasm and cerebral ischaemia in subarachnoid haemorrhage
    Viderman, Dmitriy
    Tapinova, Karina
    Abdildin, Yerkin G.
    CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING, 2023, 43 (01) : 1 - 9
  • [2] Nicaraven for the treatment of cerebral vasospasm in subarachnoid haemorrhage
    Jain, KK
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (04) : 859 - 870
  • [3] Diagnosis of delayed cerebral ischaemia and cerebral vasospasm in subarachnoid haemorrhage
    Rodriguez Garcia, P. L.
    Rodriguez Pupo, L. R.
    Rodriguez Garcia, D.
    NEUROLOGIA, 2010, 25 (05): : 322 - 330
  • [4] Treatment of cerebral vasospasm with cilostazol in subarachnoid haemorrhage model
    Bilginer, B.
    Onal, B.
    Yigitkanli, K.
    Soeylemezoglu, F.
    Bavbek, M.
    Ziyal, L. M.
    Ozgen, T.
    CEREBRAL VASOSPASM: NEW STRATEGIES IN RESEARCH AND TREATMENT, 2008, 104 : 291 - +
  • [5] Effects of common medications on cerebral vasospasm after subarachnoid haemorrhage
    Topcuoglu, MA
    Singhal, AB
    EXPERT OPINION ON DRUG SAFETY, 2006, 5 (01) : 57 - 65
  • [6] Pathophysiological basis of cerebral vasospasm following aneurysmal subarachnoid haemorrhage
    Khurana, VG
    Besser, M
    JOURNAL OF CLINICAL NEUROSCIENCE, 1997, 4 (02) : 122 - 131
  • [7] Machine learning predicts cerebral vasospasm in patients with subarachnoid haemorrhage
    Zarrin, David A.
    Suri, Abhinav
    McCarthy, Karen
    Gaonkar, Bilwaj
    Wilson, Bayard R.
    Colby, Geoffrey P.
    Freundlich, Robert E.
    Gabel, Eilon
    EBIOMEDICINE, 2024, 105
  • [8] The effectiveness of acupuncture treatment on cerebral vasospasm after aneurysmal subarachnoid haemorrhage
    Ko, C-N.
    Cho, S-Y.
    Park, S-U.
    Park, J-M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 256 - 256
  • [9] Participation of vasopressin in the development of cerebral vasospasm in a rat model of subarachnoid haemorrhage
    Trandafir, CC
    Nishihashi, T
    Wang, AM
    Murakami, S
    Ji, X
    Kurahashi, K
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2004, 31 (04): : 261 - 266
  • [10] Magnesium protection against in vitro cerebral vasospasm after subarachnoid haemorrhage
    Pyne, GJ
    Cadoux-Hudson, TAD
    Clark, JF
    BRITISH JOURNAL OF NEUROSURGERY, 2001, 15 (05) : 409 - 415